stem cells « Science and Enterprise

Cell-Based Fish Company Gains $8.25M in Seed Funds

By Alan, on March 26th, 2021%

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Biotech Manufacturer Gains $525M in New Funds

By Alan, on March 15th, 2021%

A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round. . . . → Read More: Biotech Manufacturer Gains $525M in New Funds

In-Body Gene Editing Tested as Sickle Cell Treatment

By Alan, on March 11th, 2021%

Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease. . . . → Read More: In-Body Gene Editing Tested as Sickle Cell Treatment

ALS Trial Results Deemed Insufficient for FDA Approval

By Alan, on February 23rd, 2021%

An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use. . . . → Read More: ALS Trial Results Deemed Insufficient for FDA Approval

Engineered Cell Therapy Company Issues $588M IPO

By Alan, on February 4th, 2021%

A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO. . . . → Read More: Engineered Cell Therapy Company Issues $588M IPO

Biotech Licenses mRNA Technology for Aging

By Alan, on January 13th, 2021%

A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging

Stem Cells Help Severe Covid-19 Cases Recover

By Alan, on January 6th, 2021%

Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover

Trial OKed for Rare Disease Gene Therapy

By Alan, on January 4th, 2021%

A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy

ALS Stem Cell Treatments Found Safe, Slow Progression

By Alan, on December 15th, 2020%

Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease. . . . → Read More: ALS Stem Cell Treatments Found Safe, Slow Progression

Trial Shows Stem Cell Therapy Slows M.S. Progression

By Alan, on December 8th, 2020%

Results of a clinical trial show a treatment for multiple sclerosis from patients’ stem cells slows progression of the disease and improves walking ability. . . . → Read More: Trial Shows Stem Cell Therapy Slows M.S. Progression

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise